1. Home
  2. Presentation
  3. Modeling FTDP-17 linked tauopathies and Alzheimer’s disease with human iPSC

Modeling FTDP-17 linked tauopathies and Alzheimer’s disease with human iPSC

Modeling FTDP-17 linked tauopathies and Alzheimer's disease with human iPSC

Dr An Verheyen, Janssen R&D Discovery Services presented her work at ISSCR Basel, 2017. Dr Verheyen used human iPSC-derived neural cells generated using our custom differentiation service to model tauopathies linked to frontotemporal dementia with parkinsonism-17 and Alzheimer’s disease.